Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Enanta Pharmaceuticals (ENTA) Equity Ratio (2016 - 2025)

Historic Equity Ratio for Enanta Pharmaceuticals (ENTA) over the last 14 years, with Q4 2025 value amounting to 0.38.

  • Enanta Pharmaceuticals' Equity Ratio rose 1978.96% to 0.38 in Q4 2025 from the same period last year, while for Dec 2025 it was 0.38, marking a year-over-year increase of 1978.96%. This contributed to the annual value of 0.23 for FY2025, which is 3259.32% down from last year.
  • According to the latest figures from Q4 2025, Enanta Pharmaceuticals' Equity Ratio is 0.38, which was up 1978.96% from 0.23 recorded in Q3 2025.
  • In the past 5 years, Enanta Pharmaceuticals' Equity Ratio registered a high of 0.93 during Q1 2021, and its lowest value of 0.23 during Q3 2025.
  • Its 5-year average for Equity Ratio is 0.6, with a median of 0.47 in 2023.
  • Per our database at Business Quant, Enanta Pharmaceuticals' Equity Ratio crashed by 5132.3% in 2024 and then surged by 1978.96% in 2025.
  • Quarter analysis of 5 years shows Enanta Pharmaceuticals' Equity Ratio stood at 0.87 in 2021, then dropped by 0.78% to 0.87 in 2022, then tumbled by 48.27% to 0.45 in 2023, then dropped by 28.38% to 0.32 in 2024, then grew by 19.79% to 0.38 in 2025.
  • Its Equity Ratio was 0.38 in Q4 2025, compared to 0.23 in Q3 2025 and 0.26 in Q2 2025.